502 results on '"Click, Benjamin"'
Search Results
2. Clinical Update on the Prevention and Management of Postoperative Crohn’s Disease Recurrence
3. Real-world effectiveness and safety of ustekinumab and vedolizumab in elderly patients with Crohn’s disease
4. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease
5. Sweet Syndrome Associated with Active Inflammatory Bowel Disease: A Case Series of a Rare Extra-intestinal Manifestation
6. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease
7. Postoperative Surveillance and Management of Crohn Disease
8. The IBD Clinic of Tomorrow: Holistic, Patient-Centric, and Value-based Care
9. Crohn’s Disease Is Associated with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
10. Real-World Effectiveness and Safety of Ustekinumab in Elderly Crohn’s Disease Patients
11. Postoperative Crohn’s Disease Recurrence Risk and Optimal Biologic Timing After Temporary Diversion Following Ileocolic Resection
12. A Practical Approach to Subcutaneous Infliximab (Zymfentra)
13. Malignancy risk in individuals with familial adenomatous polyposis receiving biologics and immunomodulators
14. Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease
15. Rates of Intestinal Resection and Colectomy in Inflammatory Bowel Disease Patients After Initiation of Biologics: A Cohort Study
16. Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD
17. The Economics of IBD: Is There a Future for a Medical Home?
18. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn's Disease Recurrence.
19. Safety and Monitoring of Inflammatory Bowel Disease Advanced Therapies.
20. Change in Biologic Class Promotes Endoscopic Remission Following Endoscopic Postoperative Crohn’s Disease Recurrence
21. S1057 Early, Severe Postoperative Recurrence of Crohn’s Disease – Natural History, Predictors, and Outcomes
22. S1084 Risk Factors for Late Postoperative Recurrence of Crohn’s Disease: A Multicenter Retrospective Cohort Study
23. Real-World Surgical and Endoscopic Recurrence Based on Risk Profiles and Prophylaxis Utilization in Postoperative Crohn’s Disease
24. Safety and Efficacy of Bariatric Surgery in Inflammatory Bowel Disease Patients: a Systematic Review and Meta-analysis
25. Pouch Function Over Time and With Advancing Age
26. Ileocolic Resection for Crohn Disease: The Influence of Different Surgical Techniques on Perioperative Outcomes, Recurrence Rates, and Endoscopic Surveillance
27. Mesenteric Excision and Exclusion for Ileocolic Crohn’s Disease: Feasibility and Safety of an Innovative, Combined Surgical Approach With Extended Mesenteric Excision and Kono-S Anastomosis
28. Special Considerations for Colorectal Surgery in the Elderly IBD Patient
29. Use of Biologics in the Postoperative Management of Crohn’s Disease
30. Targeting anti-fibrotic pathways in Crohn’s disease – The final frontier?
31. Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home
32. Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases.
33. American Gastroenterological Association-Proposed Fecal Calprotectin Cutoff of 50 ug/g is Associated With Endoscopic Recurrence in a Real-World Cohort of Patients With Crohn's Disease Post-ileocolic Resection.
34. Anal Squamous Cell Carcinoma in Ulcerative Colitis: Can Pouches Withstand Traditional Treatment Protocols?
35. Anastomotic Configuration and Temporary Diverting Ileostomy Do Not Increase Risk of Anastomotic Stricture in Postoperative Crohn's Disease
36. The burden of cost in inflammatory bowel disease: a medical economic perspective
37. Low Rates of Dermatologic Care and Skin Cancer Screening Among Inflammatory Bowel Disease Patients
38. Preoperative Use of Multiple Advanced Therapies Is Not Associated With Endoscopic Inflammatory Pouch Diseases
39. Management of Isolated Anal Strictures in Crohn’s Disease
40. Telephone Encounters in Inflammatory Bowel Disease (IBD) Care: Burden, Risk Factors, and Opportunities for Intervention
41. Constructing an Inflammatory Bowel Disease Patient–Centered Medical Home
42. The Burden of Cost in Inflammatory Bowel Disease: A Medical Economic Perspective and the Future of Value-Based Care
43. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease
44. Proactive Versus Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: Is the Juice Worth the Squeeze?
45. The Inflammatory Bowel Disease Medical Home: From Patients to Populations
46. Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease
47. A Practical Guide to the Safety and Monitoring of New IBD Therapies
48. Lasting Impact of Clostridium difficile Infection in Inflammatory Bowel Disease: A Propensity Score Matched Analysis
49. The role of apheresis in hypertriglyceridemia-induced acute pancreatitis: A systematic review
50. S17 Treatment Patterns Among Moderate-to-Severe Ulcerative Colitis Patients in TARGET-IBD
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.